Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-25-005343
Filing Date
2025-08-19
Accepted
2025-08-19 15:24:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3656
  Complete submission text file 0001959173-25-005343.txt   5161
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Subject) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 000-24006 | Film No.: 251231394
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address
Business Address
ROBIN HOWARD W (Reporting) CIK: 0001206869 (see all company filings)

Type: 144